Skip to main content

Lupus

      RT @ericdeinmd: #ACR21 Ab#1029 - Great poster by Dr. Guttmann, IRAD in Summit NJ:
      ▶️2019 EULAR/ACR SLE criteria vs t
      3 years 2 months ago
      #ACR21 Ab#1029 - Great poster by Dr. Guttmann, IRAD in Summit NJ: ▶️2019 EULAR/ACR SLE criteria vs to 1997 ACR & SLICC ⭐️64% SLE pts: all 3 criteria. 10% only SLICC, 3% '97 ACR, 2% EULAR/ACR ⭐️Simliar gender, racial disparities to prior criteria @Rheumnow https://t.co/QzG78HJgw5 https://t.co/eyuYhj4Acf
      RT @ericdeinmd: #ACR21 Abs:#1429: ALPN-303: Dual BAFF/APRIL antagonist for SLE:
      ⭐️Encouraging immunomodulatory activ
      3 years 2 months ago
      #ACR21 Abs:#1429: ALPN-303: Dual BAFF/APRIL antagonist for SLE: ⭐️Encouraging immunomodulatory activity and efficacy in animal models. ⬇️ Plasma cells and Ig secretions in vitro & vivo ⭐️Well-tolerated in animals w/o adverse events 🔥Phase 1 study in healthy volunteers! @Rheumnow
      RT @Yuz6Yusof: #ACR21 #Abstr1420 A study checking #COVID vaccine response in 90 #lupus pts and 20 HC:
      ⬇️Titres of Ab
      3 years 2 months ago
      #ACR21 #Abstr1420 A study checking #COVID vaccine response in 90 #lupus pts and 20 HC: ⬇️Titres of Abs in SLE vs controls 💠Factors of poor response: On any DMARDs exc HCQ only (OR 15) and normal dsDNA 📢Important to pause DMARDs in stable SLE @RheumNow https://t.co/USovFkiCRb https://t.co/bn5CC0xRS9
      RT @Yuz6Yusof: 📢#ACR21 #Abstr1421 Is #COVID19 vaccine safe and effective in #lupus? YES!! VOCOLUP study (N=1189 pts)
      3 years 2 months ago
      📢#ACR21 #Abstr1421 Is #COVID19 vaccine safe and effective in #lupus? YES!! VOCOLUP study (N=1189 pts) showed: 💠~45% had a side-effect; of which 80% mild/moderate 💠Only 3% flared post💉(MSK + Fatigue); 10 required hospitalisation @RheumNow #ACRBest https://t.co/WF4aAfiX70 https://t.co/jc0HQoJymo
      RT @DrMiniDey: Young patients with #SLE #lupus have a #multimorbidity burden similar to individuals 30years older than t
      3 years 2 months ago
      Young patients with #SLE #lupus have a #multimorbidity burden similar to individuals 30years older than them. A high #comorbidity burden is present in SLE pts of all ages compared to non-SLE. How can we address this? Abs#1049 #ACR21 #ACRBest @RheumNow https://t.co/U6t8YBFUZz https://t.co/v7Fwof1gZc
      Watch: Lupus Updates: Dr. Michelle Petri

      Dr. Michelle Petri offers perspective and insight into lupus related data pr
      3 years 2 months ago
      Watch: Lupus Updates: Dr. Michelle Petri Dr. Michelle Petri offers perspective and insight into lupus related data presented Saturday at the #ACR21 annual meeting. https://t.co/L7T2mNJVH0 https://t.co/MCQ7nJjCIY
      ×